Yahoo Web Search

Search results

1. • Q4 2023 DURECT Corp Earnings Call

     Thomson Reuters StreetEvents via Yahoo Finance· 2 months ago

     Participants Tim Papp; Chief Financial Officer; DURECT Corp James Brown; President, Chief Executive Officer, Director; DURECT Corp Norman Sussman; Chief Medical Officer; DURECT Corp Keith Lui ...

2. • Durect Corp (DRRX) Q1 2024 Earnings Call Transcript Highlights: Navigating Financial Challenges ...

     GuruFocus.com via Yahoo Finance· 2 weeks ago

     Total Revenue: $1.8 million in Q1 2024, down from $2.1 million in Q1 2023. R&D Expenses: $4.1 million in Q1 2024, decreased from $8.6 million in Q1 2023. SG&A Expenses: $3.1 million in Q1 2024 ...

3. • Durect: Q4 Earnings Snapshot

     Associated Press Finance via Yahoo Finance· 2 months ago

     CUPERTINO, Calif. (AP) — CUPERTINO, Calif. (AP) — Durect Corp. (DRRX) on Wednesday reported a loss of $1.4 million in its fourth quarter. The Cupertino, California-based company said it had ...

4. • 

     What Now After FDA AdComm Rebuke for Intercept Pharmaceutical? Analyst Says Approval Of Intercept's...

     Benzinga via Yahoo Finance· 1 year ago

     On Friday, FDA's Gastrointestinal Drugs Advisory Committee voted 12 to 2—with two abstentions—that...